APA

Bays H. E., Ose L., Fraser N., Tribble D. L., Quinto K., Reyes R., Johnson-Levonas A. O., Sapre A. & Donahue S. R. (20050329). A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia. : Clinical therapeutics.

Chicago

Bays Harold E, Ose Leiv, Fraser Neil, Tribble Diane L, Quinto Katherine, Reyes Robert, Johnson-Levonas Amy O, Sapre Aditi and Donahue Steven R. 20050329. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia. : Clinical therapeutics.

Harvard

Bays H. E., Ose L., Fraser N., Tribble D. L., Quinto K., Reyes R., Johnson-Levonas A. O., Sapre A. and Donahue S. R. (20050329). A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia. : Clinical therapeutics.

MLA

Bays Harold E, Ose Leiv, Fraser Neil, Tribble Diane L, Quinto Katherine, Reyes Robert, Johnson-Levonas Amy O, Sapre Aditi and Donahue Steven R. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia. : Clinical therapeutics. 20050329.